Avid Bioservices to be Acquired in $1.1 Billion Deal
Company Announcements

Avid Bioservices to be Acquired in $1.1 Billion Deal

Avid Bioservices ( (CDMO) ) just unveiled an announcement.

Avid Bioservices, a biologics contract development and manufacturing organization, is set to be acquired by GHO Capital Partners and Ampersand Capital Partners in a $1.1 billion all-cash transaction. Shareholders will receive $12.50 per share, representing a premium to recent trading prices. The merger is expected to close in early 2025, subject to customary conditions and approvals. This acquisition aims to leverage the expertise and capital of GHO and Ampersand to propel Avid’s growth and market reach.

Learn more about CDMO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAvid Bioservices downgraded to Sector Perform from Outperform at RBC Capital
TheFlyAvid Bioservices trading resumes
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App